Cytogenetics and occupational exposure to solvents: a pilot study on leukemias and myelodysplastic disorders. 1990

P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
Dipartimento di Scienze Biomediche e Oncologia Umana, Università di Torino.

In a pilot study, 57 patients affected by leukemias or myelodysplastic syndromes were interviewed to identify potential exposure to organic solvents. Cytogenetic analyses were performed in 40 of the 57 patients. Unlike previous investigations, no association was found between the occurrence of chromosomal abnormalities and exposure to organic solvents. An original finding was a strong association between solvent exposure and myelodysplastic disorders (4 certainly exposed and 1 possibly exposed out of 11 patients). Such an observation warrants confirmation from case-control studies.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000753 Anemia, Refractory A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy. Refractory Anemia,Anemias, Refractory,Refractory Anemias
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute

Related Publications

P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
December 1992, British journal of industrial medicine,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
July 1993, Cancer genetics and cytogenetics,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
October 1984, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
April 1990, Archives of internal medicine,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
January 1994, Giornale italiano di medicina del lavoro,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
January 1999, Leukemia research,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
January 2003, Revista de neurologia,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
January 1993, Environmental research,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
June 2009, Sleep medicine reviews,
P Vineis, and G C Avanzi, and B Giovinazzo, and G Ponzio, and G R Cambrin, and G Ciccone
October 1998, Occupational and environmental medicine,
Copied contents to your clipboard!